View in EDS

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.

Saved in:
Bibliographic Details
Title: A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Authors: Jerby-Arnon L; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Shah P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cuoco MS; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rodman C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Su MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA., Melms JC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leeson R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA., Kanodia A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA., Mei S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Lin JR; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Wang S; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Rabasha B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zhang G; Molecular & Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA., Margolais C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ashenberg O; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Boland GM; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sullivan RJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Frederick DT; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Miao B; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Moll T; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Herlyn M; Molecular & Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA., Jenkins RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Thummalapalli R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kowalczyk MS; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Celsius Therapeutics, Cambridge, MA, USA., Cañadas I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schilling B; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany., Cartwright ANR; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Luoma AM; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Malu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shalek AK; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tirosh I; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sorger PK; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Wucherpfennig K; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schadendorf D; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany., Johnson BE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA., Rotem A; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA., Rozenblatt-Rosen O; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Garraway LA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Yoon CH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Department of Surgical Oncology, Boston, MA, USA., Izar B; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA. Electronic address: benjamin_izar@dfci.harvard.edu., Regev A; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Ludwig Center for Cancer Research at MIT, Boston, MA, USA; Massachusetts Institute of Technology, Department of Biology, Cambridge, MA, USA.
Source: Cell [Cell] 2018 Nov 01; Vol. 175 (4), pp. 984-997.e24.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30388455
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jerby-Arnon+L%22">Jerby-Arnon L</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shah+P%22">Shah P</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cuoco+MS%22">Cuoco MS</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rodman+C%22">Rodman C</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Su+MJ%22">Su MJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Melms+JC%22">Melms JC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Leeson+R%22">Leeson R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kanodia+A%22">Kanodia A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mei+S%22">Mei S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+JR%22">Lin JR</searchLink>; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rabasha+B%22">Rabasha B</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+G%22">Zhang G</searchLink>; Molecular & Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Margolais+C%22">Margolais C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ashenberg+O%22">Ashenberg O</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ott+PA%22">Ott PA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Buchbinder+EI%22">Buchbinder EI</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Haq+R%22">Haq R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hodi+FS%22">Hodi FS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Boland+GM%22">Boland GM</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+RJ%22">Sullivan RJ</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Frederick+DT%22">Frederick DT</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Miao+B%22">Miao B</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moll+T%22">Moll T</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Flaherty+KT%22">Flaherty KT</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Herlyn+M%22">Herlyn M</searchLink>; Molecular & Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Jenkins+RW%22">Jenkins RW</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Thummalapalli+R%22">Thummalapalli R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kowalczyk+MS%22">Kowalczyk MS</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Celsius Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cañadas+I%22">Cañadas I</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schilling+B%22">Schilling B</searchLink>; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Cartwright+ANR%22">Cartwright ANR</searchLink>; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Luoma+AM%22">Luoma AM</searchLink>; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Malu+S%22">Malu S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hwu+P%22">Hwu P</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bernatchez+C%22">Bernatchez C</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Forget+MA%22">Forget MA</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Barbie+DA%22">Barbie DA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shalek+AK%22">Shalek AK</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tirosh+I%22">Tirosh I</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sorger+PK%22">Sorger PK</searchLink>; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wucherpfennig+K%22">Wucherpfennig K</searchLink>; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Allen+EM%22">Van Allen EM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schadendorf+D%22">Schadendorf D</searchLink>; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Johnson+BE%22">Johnson BE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rotem+A%22">Rotem A</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rozenblatt-Rosen+O%22">Rozenblatt-Rosen O</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Garraway+LA%22">Garraway LA</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yoon+CH%22">Yoon CH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Department of Surgical Oncology, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Izar+B%22">Izar B</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA. Electronic address: benjamin_izar@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Regev+A%22">Regev A</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Ludwig Center for Cancer Research at MIT, Boston, MA, USA; Massachusetts Institute of Technology, Department of Biology, Cambridge, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413066%22">Cell</searchLink> [Cell] 2018 Nov 01; Vol. 175 (4), pp. 984-997.e24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413066 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-4172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200928674%22">00928674 </searchLink><i>NLM ISO Abbreviation: </i>Cell
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30388455
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cell.2018.09.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 984
    Titles:
      – TitleFull: A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jerby-Arnon L
      – PersonEntity:
          Name:
            NameFull: Shah P
      – PersonEntity:
          Name:
            NameFull: Cuoco MS
      – PersonEntity:
          Name:
            NameFull: Rodman C
      – PersonEntity:
          Name:
            NameFull: Su MJ
      – PersonEntity:
          Name:
            NameFull: Melms JC
      – PersonEntity:
          Name:
            NameFull: Leeson R
      – PersonEntity:
          Name:
            NameFull: Kanodia A
      – PersonEntity:
          Name:
            NameFull: Mei S
      – PersonEntity:
          Name:
            NameFull: Lin JR
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Rabasha B
      – PersonEntity:
          Name:
            NameFull: Liu D
      – PersonEntity:
          Name:
            NameFull: Zhang G
      – PersonEntity:
          Name:
            NameFull: Margolais C
      – PersonEntity:
          Name:
            NameFull: Ashenberg O
      – PersonEntity:
          Name:
            NameFull: Ott PA
      – PersonEntity:
          Name:
            NameFull: Buchbinder EI
      – PersonEntity:
          Name:
            NameFull: Haq R
      – PersonEntity:
          Name:
            NameFull: Hodi FS
      – PersonEntity:
          Name:
            NameFull: Boland GM
      – PersonEntity:
          Name:
            NameFull: Sullivan RJ
      – PersonEntity:
          Name:
            NameFull: Frederick DT
      – PersonEntity:
          Name:
            NameFull: Miao B
      – PersonEntity:
          Name:
            NameFull: Moll T
      – PersonEntity:
          Name:
            NameFull: Flaherty KT
      – PersonEntity:
          Name:
            NameFull: Herlyn M
      – PersonEntity:
          Name:
            NameFull: Jenkins RW
      – PersonEntity:
          Name:
            NameFull: Thummalapalli R
      – PersonEntity:
          Name:
            NameFull: Kowalczyk MS
      – PersonEntity:
          Name:
            NameFull: Cañadas I
      – PersonEntity:
          Name:
            NameFull: Schilling B
      – PersonEntity:
          Name:
            NameFull: Cartwright ANR
      – PersonEntity:
          Name:
            NameFull: Luoma AM
      – PersonEntity:
          Name:
            NameFull: Malu S
      – PersonEntity:
          Name:
            NameFull: Hwu P
      – PersonEntity:
          Name:
            NameFull: Bernatchez C
      – PersonEntity:
          Name:
            NameFull: Forget MA
      – PersonEntity:
          Name:
            NameFull: Barbie DA
      – PersonEntity:
          Name:
            NameFull: Shalek AK
      – PersonEntity:
          Name:
            NameFull: Tirosh I
      – PersonEntity:
          Name:
            NameFull: Sorger PK
      – PersonEntity:
          Name:
            NameFull: Wucherpfennig K
      – PersonEntity:
          Name:
            NameFull: Van Allen EM
      – PersonEntity:
          Name:
            NameFull: Schadendorf D
      – PersonEntity:
          Name:
            NameFull: Johnson BE
      – PersonEntity:
          Name:
            NameFull: Rotem A
      – PersonEntity:
          Name:
            NameFull: Rozenblatt-Rosen O
      – PersonEntity:
          Name:
            NameFull: Garraway LA
      – PersonEntity:
          Name:
            NameFull: Yoon CH
      – PersonEntity:
          Name:
            NameFull: Izar B
      – PersonEntity:
          Name:
            NameFull: Regev A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2018 Nov 01
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1097-4172
          Numbering:
            – Type: volume
              Value: 175
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cell
              Type: main
ResultId 1